A cooling body wrap for rapidly inducing hypothermia, includes: (a) a fluid-impermeable, flexible, conformable envelope; (b) a mixture of from about 20 to about 90 weight % of alkanes having a carbon chain length of between 10 and 14, and from about 10 to about 80 weight % of a gel or viscous fluid carrier in which the alkanes are relatively evenly distributed, the mixture being sealed within the envelope; (c) at least one layer of insulation adjacent to a first side of the envelope; and (d) fastening means for fastening the body wrap around a body part.
|
19. A cooling body wrap for rapidly inducing hypothermia, comprising:
(a) a fluid-impermeable, flexible, conformable envelope; (b) a mixture of from about 10 to about 75 weight % of alkanes having a carbon chain length of between 10 and 14 and from about 25 to about 90 weight % of a gel or viscous fluid carrier in which the alkanes are substantially evenly distributed, the mixture being sealed within the envelope; (c) at least one layer of insulation adjacent to a first side of the envelope; (d) a fastening means for fastening the body wrap around a part of the body; and further comprising at least two adjacent heat tubes within the envelope, at least one of the heat tubes containing a refrigerant liquid.
1. A body wrap for rapidly cooling a part of the body, comprising
(a) a phase change material having a melting point of between about -10 and 6 degrees Centigrade; (b) a gel or viscous fluid carrier in which the phase change material is substantially evenly distributed; (c) a fluid-impermeable, conformable, sealed envelope surrounding the phase change material and the carrier; (d) at least one layer of insulation adjacent to a first side of the envelope; (e) a fastener means for removably fastening the body wrap around a part of the body; and (f) a heat tube layer adjacent to an opposite, second side of the envelope, the heat tube layer being comprised of a plurality of heat tubes connected to one another.
11. A body wrap for rapidly inducing hypothermia, comprising
(a) a fluid-impermeable, flexible, conformable envelope; (b) a mixture of from about 10 to about 75 weight % of alkanes having a carbon chain length of between 10 and 14 and from about 25 to about 90 weight % of a gel or viscous fluid carrier in which the alkanes are substantially evenly distributed, the mixture being sealed within the envelope; (c) at least one layer of insulation adjacent to a first side of the envelope; (d) a fastening means for fastening the body wrap around a part of the body; and (e) a heat tube layer adjacent to a second, opposite side of the envelope, the heat tube layer being comprised of a plurality of heat tubes connected to one another.
20. A cooling body wrap for rapidly inducing hypothermia, comprising:
(a) a fluid-impermeable, flexible, conformable envelope; (b) a mixture of from about 10 to about 75 weight % of alkanes having a carbon chain length of between 10 and 14 and from about 25 to about 90 weight % of a gel or viscous fluid carrier in which the alkanes are substantially evenly distributed, the mixture being sealed within the envelope; (c) at least one layer of insulation adjacent to a first side of the envelope; (d) a fastening means for fastening the body wrap around a part of the body; and further comprising a plurality of heat tubes within a second, gel or viscous fluid-filled envelope, at least one of the heat tubes containing a refrigerant liquid with a boiling point between about 0 and about 20 degrees Centigrade.
3. A body wrap according to
4. A body wrap according to
8. A body wrap according to
9. A body wrap according to
10. A body wrap according to
12. A body wrap according to
13. A support surface according to
16. A body wrap according to
17. A body wrap according to
18. A body wrap according to
|
1. Technical Field
The present device is an unpowered body wrap containing phase change material with a melting point of between about -10 and 6 degrees Centigrade, the phase change material being distributed in a gel or viscous fluid carrier, for quick, thorough cooling of a portion of the body in the event of a stroke, heart attack, or other emergency medical condition.
2. Background Information
Rapid response is vital in the emergency treatment of strokes and heart attacks. Medical experts are finding that immediately inducing a state of hypothermia in stroke victims, for example, along with administering certain intravenous medications, ameliorates damage from a stroke. Many of the adverse effects of a stroke occur within the first few hours of the actual stroke, which is caused by blockage of a blood vessel by a blood clot. In the hypothermic state, the stroke victim's metabolic rate is reduced, which in turn reduces the adverse after-effects of the stroke, and even cheats death in some cases. To be effective, hypothermia should be induced as rapidly as possible. Quick treatment is imperative. The adverse effects of stroke include impaired motion on one side of the body, short-term memory loss, slurred speech, confusion, etc. Strokes occur spontaneously in teens and adults of any age, although they occur more frequently in older people. It is a leading cause of long-term disability and death in Americans over age 45. Rapidly reducing body temperature is also known to be helpful in treating heart attacks, head injuries, and limb amputations, and may prove to be helpful for treating other types of injuries. Cardiovascular disease is the most significant health problem in the United States today, afflicting roughly one quarter of adult Americans. If rapid body temperature reduction can be done safely by emergency personnel in the field, more patients can be saved and/or have an improved prognosis.
There is a need for an inexpensive, easy to use, portable device which can be used in the field and elsewhere to quickly drop body temperature. Ice packs rapidly lower body temperature, but they are difficult to keep in place on a patient, particularly one who is being jostled in a moving ambulance. One ice pack only covers a small area of the body. Also, most frozen ice packs do not conform easily to the shape of the body part.
The present invention is an unpowered, portable, quick cooling body wrap that can be cooled in a freezer or by any other suitable means of cooling, optionally stored in a cooler, and then quickly wrapped around the torso or other affected body part of the patient to rapidly reduce core body temperature. The body wrap of the present invention is lightweight, inexpensive, and easily conforms to the shape of the body. It can be stored in a cooler in an ambulance, for example, and used in the field. The body wrap, or "cocoon", stays cool for a sustained period. It retains its cooling effect long enough to be stored in a cooler, and/or to reduce and maintain the low body temperature during the ambulance ride to the hospital, for example. It is flexible and easy to use, and even an untrained person, such as a patient's spouse or a nursing home aide, can wrap it around an injured person, once they are directed to do so by a medically trained person.
Cooling of the skin is accomplished in the present invention by means of an envelope containing specific phase change materials (PCMs) distributed in a gel or viscous fluid carrier. The use of phase change materials also ensures that the cold temperatures are delivered to the skin in a precisely selected temperature range that has been found to induce hypothermia. That selected temperature range is the phase change temperature, or melting point of the phase change material.
The present invention provides a body wrap for rapidly cooling a part of the body, including:
(a) phase change material having a melting point of between about -10 and 6 degrees Centigrade;
(b) a gel or viscous fluid carrier in which the phase change material is substantially evenly distributed;
(c) a fluid-impermeable, conformable envelope surrounding the phase change material and the carrier;
(d) fastener means for removably fastening the body wrap around the body part; and
(e) at least one layer of insulation adjacent to the envelope.
The invention also includes a cooling body wrap for rapidly inducing hypothermia in a human body, comprising:
(a) a fluid-impermeable, flexible, conformable envelope;
(b) a mixture of from about 20 to about 90 weight % of alkanes having a carbon chain length of between 10 and 14, and from about 10 to about 80 weight % of a gel or viscous fluid carrier in which the alkanes are substantially evenly distributed, the mixture being sealed within the envelope;
(c) at least one layer of insulation adjacent to a first side of the envelope; and
(d) fastening means for fastening the body wrap around a part of the body. A preferred fifth element is a heat tube layer adjacent to an opposite, second side of the envelope, the heat tube layer being comprised of a plurality of heat tubes connected to one another.
A more complete understanding of the invention and its advantages will be apparent from the following detailed description taken in conjunction with the accompanying drawings, wherein examples of the invention are shown, and wherein:
In the following description, like reference characters designate like or corresponding parts throughout the several views. Also, in the following description, it is to be understood that such terms as "inside," "outside," "within," and the like are words of convenience and are not to be construed as limiting terms. Referring in more detail to the drawings, the invention will now be described.
Turning first to
As shown in
As shown in
To use the torso body wrap 11, the paramedic or other caregiver preferably rolls the first side 18 of the flexible body wrap inward about one third to one half of the width of the wrap, and pushes the roll under the prone or supine patient. This is somewhat similar to the way a clean bedsheet is put on a hospital bed under a prone or supine patient. The patient is then tipped slightly upward from the opposite side while the caregiver grasps the rolled side under the patient and unrolls it toward himself. Minimal movement of the patient is involved. The opposite, second side 22 of the body wrap 11 is then flipped over the top of the patient, and the first side 18 is flipped over the outside face 13 of the second side 22. It is preferred that one or more of the fasteners 15 then be fastened to minimize exposure of the patient's skin to the environment and maintain a cold "cocoon" around the patient. The patient's arms may be wrapped within the body wrap, too, though the top edge 23 of the torso body wrap 11 preferably fits up into the patient's armpits, leaving the arms free. The bottom edge 24 of the torso body wrap preferably falls along an upper portion of the legs.
The body wrap 10 is lightweight, durable, washable, easy to use, inexpensive to make, and reusable. It is usable in the field, operating room, nursing home, or even in the home of a person with a history of strokes or heart attacks. The body wrap 10 can also be used on patients in chiropractic offices or sports therapy clinics for treating musculoskeletal injuries. It can be used to temporarily reduce the severity of essential tremors in the arms, for example. It can be included in First Aid kits built for situations where these types of injuries are likely. It can be stored in a conventional or specialized cooler on a helicopter, for example, and dropped with other supplies for use by medics on the battlefield or at a field hospital pending airlift to a fully equipped hospital, or it could be used for temporarily preserving a corpse. The body wrap 10 can be used anytime and anywhere very cold temperature is desired.
If desired, the body wrap 10 can be cut down to a smaller size prior to use. A full size torso body wrap 11 can be marked with patterns for limb-sized body wraps, for example. Then the full sized wrap can be cut down to the desired size with scissors in the field. Fastening means can be located in appropriate places on the body wrap for closing the different sized wraps within the full sized wrap, particularly hook and loop strips, which do not interfere with operation of the body wrap.
As indicated in the cutaway of FIG. 1 and the cross-section of
Continuing to refer to
For body wraps herein, the phase change material 31 has a melting point, or phase change temperature, of between about -10 and 6 degrees Centigrade. The phase change material is one that is capable of being suspended in the gel or viscous fluid carrier herein. Phase change materials for use in a body wrap of the present invention have a phase change such that temperatures of the skin area covered will be brought to between about 15 and 27 degrees Centigrade. The normal core temperature ("normothermia") of the human body is between about 36°C and 38°C C. Skin temperature typically ranges between about 31°C C. and about 38°C C.
To use the body wrap 10, it is cooled in a freezer, or refrigerator, or by other cooling means at a temperature cool enough to cause solidification of a majority of the included phase change material after about 20 to 60 minutes in the freezer. The body wrap 10 can then be stored in a cooler before being wrapped around the body part. The body wrap can only be stored in the cooler for a finite period, depending upon the phase change temperature of the phase change material 31 and the cooling capacity of the cooler. The body wrap 10 cannot be stored indefinitely in the cooler; it must be refrozen to drop the temperature back down to phase change if it is allowed to warm for too long. The body wrap 10 can be frozen and allowed to warm back to room temperature many times over many years, without a discernable dropoff in efficacy. It can be stored at room temperature for long periods. It is preferably washable, although it is also inexpensive enough for a layperson to be able to afford a replacement if disposal is desired.
By maintaining the body temperature at a level sufficient to induce hypothermia, the body metabolism is significantly lowered, resulting in fewer adverse effects from the condition being treated. The body wrap will then maintain the temperature within the prescribed range for a predictable period of time. In other words, the body wrap 10 will ordinarily maintain the low body temperature until the patient can be transported to an operating room or a fully equipped emergency room, for example.
The viscous fluid or gel carrier 30 in which the phase change material 31 may be suspended is contained within the thin, fluid impermeable, conformable envelope 28. The concentration of phase change material 31 to carrier 30 by weight is preferably between about 1:4 and 4:1 (most preferably about 60 PCM: 40 carrier). This ratio has generally been found to be of importance because, for most types of phase change materials and carriers, the more phase change material that is added to the carrier beyond a certain minimal level, the stiffer and firmer the mixture becomes. Although in general more phase change material means better and longer cooling, too much phase change material has been found to produce an overly bulky, unacceptably rigid envelope. The body wraps of the present invention are relatively thin and flexible, despite the phase change material 31 and carrier 30 in the envelope.
Without meaning to be bound by theory, it is believed that leaving about ¼ of the phase change material unmelted ensures that the body wrap 10 will not be overcooled when it is cooled by dry ice. As long as some phase change material remains in the opposite state, the temperature of the envelope 28 will not exceed its phase change temperature.
Phase change materials are normally classified according to their melting points. Since most phase change materials are not pure, they melt over a range of one or two degrees of temperature. When they are frozen to a temperature within the specified temperature range, the bulk of the liquid phase change materials within the phase change material mixture will solidify. Many variables contribute to the performance of the body wrap, including the type of phase change material and carrier, whether the phase change material is encapsulated, how long it is cooled, the size of the body wrap 10, and the body temperature, lean body mass, and subcutaneous fat level of the patient on whom the body wrap is applied. As the phase change material provides cold temperatures to the skin below the envelope. Because the phase change material's phase change occurs at a specific temperature, the cold is only delivered at this specific temperature, or slightly more than it, depending upon the thickness of the insulation between the PCM-containing envelope 28 and the wrapped area of the body. This makes it ideal for temperature-controlled application of cold temperatures.
In general, the cold phase change material 31 cools the carrier 30, which cools the envelope 28, which cools the insulation layer 27, which lowers the patient's skin temperature and ultimately, with sustained application over a broad area, induces hypothermia. Preferably, once the phase change material 31 is cold, the body wrap 10 cools the user's skin to between about 15 and 27 degrees Centigrade for between about 30 minutes and four hours. The temperature of the carrier and the phase change material suspended in it must be a few degrees colder than this in order to drive cold temperature toward the body. Some cold will be lost to the environment once the body wrap 10 is wrapped around the user's body, but the rate of warming from the environment will be reduced by the outer insulation layer.
Suitable phase change materials for cooling applications herein include C12 to C14 alkanes (i.e., alkanes with between about 12 and 14 carbons), and mixtures thereof. Preferred alkanes for use herein, then, are dodecane (C12), tridecane (C13), and tetradecane (C14). The alkanes used in this invention can be varied according to the degree of cooling necessary for the particular part of the body on which the body wrap 10 will be used, the length of time that cooling is desired, or the patient's particular condition (stroke, heart attack, etc.). Alkanes may be selected according to the degree of cooling necessary to achieve the desired cooling effect. Alkanes may also be selected and mixed based on budget constraints, since some of them are more expensive than others.
Phase change material 31 for use herein is preferably microencapsulated so that it remains evenly distributed throughout the carrier 30 even after many cooling/warming cycles. This is important because many phase change materials, such as the alkanes, are by themselves poor thermal conductors. Alkanes are also hard, waxy, and not conformable in the solid state. The distribution of the phase change material into small, generally spherical capsules with a diameter of between about one and 100 microns significantly enhances heat transfer between the surrounding medium and the phase change material. It also allows the mass to conform to the body as the liquid or gel carrier between capsules allows them to slide relative to one another despite the fact that the frozen PCM itself is rigid. Microencapsulation also prevents interaction, chemical or otherwise, over time between the phase change material and the carrier or envelope material, thus increasing product durability. Any suitable method for encapsulating the phase change material in a protective coating can be utilized. Powder phase change material is preferably used because it is believed to have good conductivity due to its higher surface area and distributes well into a conformable PCM/carrier mixture. The phase change materials are preferably microencapsulated in a thin coating, more preferably a polymer. The coating preferably forms a generally spherical shell around the phase change material with a preferred shell thickness of between about 0.003 and two microns, most preferably about 0.05 micron.
The body wraps 10 herein are not powered and do not comprise a power source. Since the body wrap is pre-cooled, it does not have to be attached to an electrical source or batteries while it is on the patient, nor is control circuitry necessary in order for the envelope 28 to remain cold for the specific period of time. The body wrap 10 does not include a microprocessor, EEPROM, or the like.
Prior to using the body wrap 10, it is placed in a freezer to cool. Other means of cooling, such as refrigeration or dry ice, may be employed. Special care should be taken at the lower end of the temperature range (-10 degrees C.) because an uninsulated envelope 28 could conceivably harm a patient's skin.
As shown in
Various systems can be used for determining when the body wrap 10 is cooled to the appropriate degree. The simplest and most preferred system is to keep the body wrap in a freezer that is set to approximately five degrees cooler than the phase change temperature. After about 20 minutes in the freezer, the body wrap is ready for immediate use as needed. Another system utilizes a small thermal window 32 or slit on the outer face 13 of the body wrap 10. A color-coded window may be included on the body wrap, or on a wrapper around it. The thermal window 32 allows the user to view a thermal indicator placed inside the body wrap, which senses the temperature of the envelope 28. The thermal indicator changes in some visible way, such as a color change, to indicate to the user that the PCM-containing carrier has been cooled to the pre-determined temperature. This system is inexpensive because a conventional freezer can be employed. A color-coded temperature indicator may also be applied directly on the inside or outside faces of the body wrap.
Another way for the user to determine when the body wrap is properly chilled is a thermometer 33, as shown on the head body wrap 12 in FIG. 1. The lower end of the thermometer rests inside the body wrap, preferably in, on or very near the envelope 28. When the pre-determined temperature is reached, the body wrap 12 can be removed from the freezer and used.
The fluidic PCM/carrier contents are enclosed by the flexible envelope 28, which is then preferably heat sealed along its edges. In a preferred embodiment, the envelope 28 is urethane film, the carrier 30 is a silicone fluid, and the phase change material 31 is C12 and C14 alkane encapsulated into microcapsules having a diameter between about one and 100 microns. The envelope 28 is preferably made of a urethane film with a thickness of between about 0.003 and 0.08 inch. The shape and size of the envelope may be varied. The envelope 28 itself is preferably between about 0.1 and 1.5 inches thick, most preferably one inch thick. The envelope 28 may include internal divisions to isolate PCM microcapsules into pockets. The body wrap 10 and/or envelope 28 may, for example, be quilted, with a small amount of phase change material and carrier in each quilt square. The body wrap 10 is preferably between about 0.5 and five inches thick, more preferably between about one and two inches thick.
The PCM-containing envelope is preferably sandwiched between the conformable thermal insulation layers 27, which are preferably made of thin sheets of hollow fiber polymer, or any other suitable insulative, soft, cushioning, comfortable, absorbent, conformable material. The primary function of the insulation layer is to limit the escape of cold from the envelope, and protect the skin from the cold temperatures.
The phase change material is substantially evenly distributed in the carrier 30 which is a gel, such as a urethane gel or a viscous fluid. By "viscous fluid" is meant a fluid with an absolute viscosity between about five and about 100,000 centipoise, most preferably between about five and about 10,000 centipoise. Generally, the carrier stiffens as phase change material is added. Carriers 30 with a lower viscosity are preferable herein because the envelope 28 will be soft and flexible. Urethane gels, silicone fluids, and mineral oils are among the suitable carriers in this regard. It is also believed that inexpensive oils, such as vegetable oil, olive oil, or peanut oil, may also be employed herein, so long as they have a suitably high viscosity and a preservative is included. The carrier 30 and phase change material 31 are both preferably non-toxic, and mixable. The phase change material must maintain distribution within the carrier through many cold/warm cycles. The viscous, conformable fluid carrier herein should be one that does not foster bacterial or fungal growth when confined in the air- and fluid-impermeable envelope.
It is believed that a viscous fluid is optimal herein for maintaining phase change material distribution and for even cooling. Viscosity is a significant property of the material that is selected to carry the phase change material because it determines, in large part, the conformability of the PCM/carrier mixture and the extent to which an even distribution can be maintained over many use cycles. Viscosity is basically the resistance to change of form exhibited by a fluid. It is a measure of internal friction and is measured as the amount of tangential force exerted by one layer of fluid upon an adjacent layer as it driven across it at a given velocity. The viscosity of the fluid carrier has been found to affect conformability and flexibility of the present invention. The viscosity also affects the tendency for a dispersed powder phase change material to maintain its dispersion. For this reason, very low viscosity fluids, such as water and alcohol, are believed not to be desirable as carriers herein. Polydimethylsiloxane fluid and dimethicone fluid are more preferred for use herein.
Turning to
In a less preferred embodiment, at least one hollow heat tube 36, and preferably all of the heat tubes, holds a small amount of a refrigerant liquid 37, as shown in FIG. 3. The refrigerant liquid 37 has a boiling point between about 0 and 20 degrees Centigrade. Each heat tube contains only a small amount of the refrigerant liquid; sufficient empty space remains in each heat tube for expansion of the refrigerant liquid. The heat tube layer is enclosed, so that the refrigerant 37 does not escape from the heat tube layer 35.
The heat tubes are made of a flexible material, so that they are comfortable to sit or lie on. The heat tube material must be strong and able to contain the refrigerant and withstand the liquid to gas expansion. The heat tubes are preferably substantially made of a gas impermeable film.
Referring to
It has been found herein that one problem with some of the heat tube materials is that they crackle when a user sits or lies on them. In all embodiments herein, the heat tubes 36 may be surrounded by a second gel or viscous fluid, such as a silicone gel, and enclosed by a second envelope. The fluid/gel muffles the distracting crackling sound. This second envelope preferably lies side by side with the first, PCM-containing envelope 28. Another alternative is to include the heat tubes 36 in the PCM-containing envelope 28. The carrier 30 around the heat tubes 36 in the envelope 28 then muffles the crackling sound.
From the foregoing it can be realized that the described cooling body wrap of the present invention may be easily and conveniently utilized. It is to be understood that any dimensions given herein are illustrative, and are not meant to be limiting.
While preferred embodiments of the invention have been described using specific terms, this description is for illustrative purposes only. It will be apparent to those of ordinary skill in the art that various modifications, substitutions, omissions, and changes may be made without departing from the spirit or scope of the invention, and that such are intended to be within the scope of the present invention as defined by the following claims. It is intended that the doctrine of equivalents be relied upon to determine the fair scope of these claims in connection with any other person's product which fall outside the literal wording of these claims, but which in reality do not materially depart from this invention.
Without further analysis, the foregoing will so fully reveal the gist of the present invention that others can, by applying current knowledge, readily adapt it for various applications without omitting features that, from the standpoint of prior art, fairly constitute essential characteristics of the generic or specific aspects of this invention.
10 body wrap
11 torso body wrap
12 head body wrap
13 outside face
14 inside face
15 fastening means
16 first fastening members
17 second fastening members
18 first side of torso body wrap
19 cutout in head body wrap
20 left neck flap of head body wrap
21 right neck flap of head body wrap
22 second side of body wrap
23 top edge of body wrap
24 bottom edge of body wrap
26 outer protective layer
27 insulation layer
28 envelope
29 inner layer
30 carrier
31 phase change material
32 temperature indicator window
33 thermometer
35 heat tube layer
36 heat tube
37 refrigerant
38 net in heat tube
Lachenbruch, Charles A., Barnett, Richard I.
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
4391267, | Apr 15 1981 | Allegiance Corporation | Heat storage material |
4596250, | Nov 14 1984 | Genetic Laboratories, Inc. | Moldable cooling/heating device with directional cooling/heating |
4667658, | Jun 16 1981 | Sunset Ltd. | Thermotherapy technique |
4671267, | May 30 1984 | Edward I., Stout | Gel-based therapy member and method |
4708812, | Jun 26 1985 | Union Carbide Corporation | Encapsulation of phase change materials |
4756299, | Sep 22 1986 | Hypertherm Technologies, Inc.; HYPERTHERM TECHNOLOGIES, INC , 9424 SHERIDAN ROAD, KENOSHA, WISCONSIN, A WISCONSIN CORP | Chemical heating pad with differing air-admitting perforation sets for different heat-generation levels |
4914717, | Feb 13 1989 | Jamak Fabrication-Tex, LLC | Microwave actuable heating pad and method |
4964402, | Aug 17 1988 | Royce Medical Company | Orthopedic device having gel pad with phase change material |
4981135, | Jun 16 1989 | Therapeutic thermal cuff | |
5069208, | May 16 1986 | Term-ac S.A. | Therapeutic device comprising a mass of a thermally active material |
5072455, | Jul 31 1987 | Heat-intercepting garment or blanket | |
5088487, | Sep 06 1990 | JACKSON, CECIL R ; COLLARD, GERALD L | Body wrap with pocket for pliable frozen composition |
5094238, | Nov 16 1990 | Jamak Fabrication-Tex, LLC | Moldable body pad |
5098621, | Jan 07 1985 | Twin Rivers Engineering | Method of forming a foam substrate and micropackaged active ingredient particle composite |
5190031, | Mar 11 1991 | Universal thermotherapy applicator | |
5211949, | Jan 09 1990 | University of Dayton | Dry powder mixes comprising phase change materials |
5275156, | Jul 13 1992 | Nova Design Partners, L.P. | Reusable heat releasing pack |
5277180, | Mar 05 1990 | Covidien AG | Absorbent pad and thermal pack |
5334646, | Mar 17 1977 | Applied Elastomerics, Inc.; APPLIED ELASTOMERICS, INC | Thermoplastic elastomer gelatinous articles |
5366801, | May 29 1992 | Outlast Technologies LLC | Fabric with reversible enhanced thermal properties |
5431622, | Aug 10 1992 | Okanagan House Inc. | Thermal bandage |
5443487, | Mar 05 1993 | Combined chemo-thermo therapy technique | |
5456704, | Apr 21 1994 | Method of treatment with therapeutic moist heating pad | |
5456852, | May 06 1993 | Mitsubishi Paper Mills Limited | Microcapsule for heat-storing material |
5486207, | Sep 20 1994 | Thermal pad for portable body heating/cooling system and method of use | |
5630961, | Sep 21 1993 | R G BARRY CORPORATION | Microwave-activated mixed-powder thermal storage material; and method |
5637389, | Feb 18 1992 | BAYCHAR, | Thermally enhanced foam insulation |
5713143, | Jun 06 1995 | Kendall Orthotics | Orthotic system |
5722482, | Jul 14 1992 | Phase change thermal control materials, method and apparatus | |
5737774, | Sep 18 1993 | Spine-Issimus Limited | Device for preventing or reducing the incidence or intensity of pain in the body |
5750962, | Feb 27 1995 | Vesture Corporation | Thermal retention device |
5932129, | Feb 27 1995 | PHASE CHANGE ENERGY SOLUTIONS, INC | Thermal retention device |
5984953, | May 21 1998 | TEMPRA TECHNOLOGY, INC | Self-regulating heat pack |
5993480, | Jan 13 1997 | Microwavable heating pad with heat activated fragrance | |
6004662, | Jul 14 1992 | Flexible composite material with phase change thermal storage | |
6007572, | Apr 30 1998 | PHASE CHANGE ENERGY SOLUTIONS, INC | Thermal seat and method for using a thermal seat |
6083254, | Mar 22 1996 | Reusable hot/cold therapeutic compress appliance | |
6099894, | Jul 27 1998 | Outlast Technologies LLC | Gel-coated microcapsules |
6120530, | Dec 07 1998 | The United States of America as represented by the Secretary of the Navy | Passive thermal capacitor for cold water diving garments |
6132455, | Feb 05 1999 | LIU, ROGER | Cooling comfort seat cushion |
6179879, | Mar 24 1999 | JPMORGAN CHASE BANK, N A , AS SUCCESSOR ADMINISTRATIVE AGENT | Leather impregnated with temperature stabilizing material and method for producing such leather |
6183855, | Jul 14 1992 | Flexible composite material with phase change thermal storage |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Nov 11 2006 | 4 years fee payment window open |
May 11 2007 | 6 months grace period start (w surcharge) |
Nov 11 2007 | patent expiry (for year 4) |
Nov 11 2009 | 2 years to revive unintentionally abandoned end. (for year 4) |
Nov 11 2010 | 8 years fee payment window open |
May 11 2011 | 6 months grace period start (w surcharge) |
Nov 11 2011 | patent expiry (for year 8) |
Nov 11 2013 | 2 years to revive unintentionally abandoned end. (for year 8) |
Nov 11 2014 | 12 years fee payment window open |
May 11 2015 | 6 months grace period start (w surcharge) |
Nov 11 2015 | patent expiry (for year 12) |
Nov 11 2017 | 2 years to revive unintentionally abandoned end. (for year 12) |